Home » Topics » BioWorld Science

BioWorld Science
RSS

Study finds variants that increase risk of severe COVID-19

March 8, 2022

METTL3 inhibition with STM-2457 leads to antitumor effects in OSCC

March 8, 2022

LABP-73 demonstrates efficacy in preclinical models of chronic asthma

March 8, 2022

BMAL1 disruption has an impact on metabolic and liver disease

March 8, 2022

Nanoengineered Bifidobacterium bifidum suppresses tumors in vivo

March 8, 2022

VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model

March 7, 2022

Modulation of RICTOR/mTORC2 axis is an approach for sensorineural hearing loss

March 7, 2022

Regulation of BIN1 ameliorates dynamin-related myopathy

March 7, 2022

Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells

March 7, 2022

PEAK3 promotes cell proliferation and migration in vitro

March 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...